Shareholding disclosure

GEFIM SPA

Declared position

4.41%

Threshold

Crossed upwards

Timeline

Published

10.10.2017

Transaction

03.10.2017

Voting rights breakdown

Voting rights acquired4.41%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAHA500045

Beneficial owner

GEFIM SPA

Declared address

GEFIM SPA, MILAN

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

GEFIM SPA

Newron Pharmaceuticals S.p.A.10.10.2017TAHA500045

Disclosure summary

GEFIM SPA disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 10.10.2017, at 4.41% of voting rights. Notice category: Single shareholder.

Disclosed position

4.41%

Voting rights acquired

Voting rights acquired4.41%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

GEFIM SPA disclosed a holding in Newron Pharmaceuticals S.p.A., published on 10.10.2017.

Publication date10.10.2017

Transaction date03.10.2017

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerGEFIM SPA

Declared addressGEFIM SPA, MILAN

CategorySingle shareholder

Voting rights acquired4.41%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAHA500045

Source: SIX Exchange Regulation · Publication date: 10.10.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open